Disease Education Resources
Neuroscience
Explore our library of Lilly-created medical education resources. Please note: These resources do not offer CME/CE credit.
Cognitive Health
“AD in 3D” Augmented Reality External Site
Experience “AD in 3D”, an immersive augmented reality tool that visualizes the stages of the Alzheimer’s disease continuum.
"AD in 3D" MED Talks: Explore the Alzheimer's Disease Continuum
Deepen your understanding of Alzheimer’s disease pathology and risk factors to enhance communication with your patients.
Identifying and Managing Risks Associated with Cognitive Decline
Hear from Dr. Rosemary Laird as she reveals her approach to identifying patients at risk for cognitive decline and share strategies for enhancing patients' cognitive health.
Neurizons Vodcast Series: Conversations about Brain Health and Alzheimer's Disease
Neurologist Dr. Bert Vargas meets with experts to explore the topics of brain health, Alzheimer’s disease, and patient care.
Practical Approaches to Cognitive Health Planning
Dr. Hemant Pandey shares a holistic approach to cognitive health, emphasizing the key role of primary care in dementia risk reduction and introducing updated guidelines and tools for comprehensive assessment and support.
Enjoyed "AD in 3D" MED Talks? Download this resource for a quick reference to five key takeaways. This guide highlights essential insights into Alzheimer's disease, making them easy to understand and apply in clinical practice.
Download this resource to deepen your understanding of the Alzheimer’s disease continuum and its progression, focusing on key clinical stages and the importance of early recognition in optimizing patient care.
With key data on disease burden and future projections, this resource highlights the rising prevalence of Alzheimer’s disease and emphasizes the vital role PCPs have in early identification and management to help mitigate long-term impact.
Explore how fluid and imaging biomarkers reflect underlying Alzheimer’s disease biology and may help inform clinical evaluation. This brief resource highlights key markers like Aβ42/Aβ40 and P‑tau and their emerging role across the AD continuum.
Explore how fluid and imaging biomarkers reflect underlying Alzheimer’s disease biology and may help inform clinical evaluation. This brief resource highlights key markers like Aβ42/Aβ40 and P‑tau and their emerging role across the AD continuum.
This resource highlights the importance of cognitive assessments, featuring user-friendly, validated digital tools. Learn about tool selection, ease of use, quality, cost, and administration in this concise tool.
Explore an overview of a study published in the Journal of Prevention of Alzheimer's Disease exploring the significance of AD biomarkers in identifying disease progression from asymptomatic disease to showing cognitive symptoms.
Explore key modifiable and non-modifiable risk factors of Alzheimer's Disease. This resource is designed for clinicians to enhance patient outcomes through informed lifestyle changes and understanding genetic influences.
Enhance clinical care with this evidence-based resource that supports early risk management, annual cognitive assessment, and brain-healthy strategies to improve patient outcomes.
Patient Education Resources
Explore our library of patient based education materials to aid in HCP to patient interactions.